Molecular pathology of the pituitary: Development and functional differentiation of pituitary adenomas

Frontiers of Hormone Research

Volumn 32, Issue , 2004, Pages 20-33

  Osamura, Robert Yoshiyuki ^a   Egashira, Noboru ^a   Miyai, Shunsuke ^a   Yamazaki, Michio ^b   Takekoshi, Susumu ^a   Sanno, Naoko ^b   Teramoto, Akira ^b  

^a TOKAI UNIVERSITY   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOPHYSIS HORMONE; TRANSCRIPTION FACTOR;

ADENOMA; ANIMAL; CELL DIFFERENTIATION; CYTOLOGY; HUMAN; HYPOPHYSIS; HYPOPHYSIS TUMOR; METABOLISM; PATHOLOGY; REVIEW; SECRETION;

ADENOMA; ANIMALS; CELL DIFFERENTIATION; HUMANS; PITUITARY GLAND; PITUITARY HORMONES; PITUITARY NEOPLASMS; TRANSCRIPTION FACTORS;

EID: 4043154326     PISSN: 03013073     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (22)

1. Takumi I, Steiner DF, Sanno N, Teramoto A, Osamura RY: Localization of prohormone convertases 1/3 and 2 in the human pituitary gland and pituitary adenomas: Analysis by immunohistochemistry, immunoelectron microscopy, and laser scanning microscopy. Mod Pathol 1998; 11:232-238.
2. Osamura RY, Watanabe K, Nakai Y, Imura H: Adrenocorticotropic hormone cells and immunoreactive β-endorphin cells in the human pituitary gland: Normal and pathologic conditions studied by the peroxidase-labeled antibody method. Am J Pathol 1980;99:105-124.
3. Osamura RY, Watanabe K: Functional differentiation of the posterior limb of Rathke's pouch in human fetal pituitary glands studied by peroxidase-labeled antibody method. Acta Histochem Cytochem 1977;10:471-477.
4. Scully KM, Rosenfeld MG: Pituitary development: Regulatory codes in mammalian organogenesis. Science 2002;295:2231-2235.
5. Adler S, Waterman ML, He X, Rosenfeld MG: Steroid receptor-mediated inhibition of rat prolactin gene expression does not require the receptor DNA-binding domain. Cell 1988;52:685-695.
6. Bodner M, Karin M: A pituitary-specific trans-acting factor can stimulate transcription from the growth hormone promoter in extracts of nonexpressing cells. Cell 1987;50:267-275.
7. Sanno N, Teramoto A, Osamura RY, Genka S, Katakami H, Jin L, Lloyd RV, Kovacs K: A growth hormone-releasing hormone-producing pancreatic islet cell tumor metastasized to the pituitary is associated with pituitary somatotroph hyperplasia and acromegaly. J Clin Endocrinol Metab 1997; 82:2731-2737.
8. Matsuno A, Katakami H, Sanno N, Ogino Y, Osamura RY, Matsukura S, Shimizu N, Nagashima T: Pituitary somatotroph adenoma producing growth hormone (GH)-releasing hormone (GHRH) with an elevated plasma GHRH concentration: A model case for autocrine and paracrine regulation of GH secretion by GHRH. J Clin Endocrinol Metab 1999;84:3241-3247.
9. Sanno N, Teramoto A, Matsuno A, Takekoshi S, Itoh J, Osamura RY: Expression of Pit-1 and estrogen receptor messenger RNA in prolactin-producing pituitary adenomas. Mod Pathol 1996;9: 526-533.
10. Umeoka K, Sanno N, Osamura RY, Teramoto A: Expression of GATA-2 in human pituitary adenomas. Mod Pathol 2002;15:11-17.
11. Sanno N, Teramoto A, Osamura RY: Clinical and cytofunctional classification of pituitary adenomas: Proposal of a new classification. Acta Neurochir (Wien) 1996;138:1186-1192.
12. Oyama K, Sanno N, Teramoto A, Osamura RY: Expression of NeuroD1 in human normal pituitaries and pituitary adenomas. Mod Pathol 2001;14:892-899.
13. Pulichino AM, Vallette Kasic S, Couture C, Gauthier Y, Brue T, David M, Malpuech G, Deal C, Van Vliet G, De Vroede M, Riepe FG, Partsch CJ, Sippell WG, Berberoglu M, Atasay B, Drouin J: Human and mouse TPIT gene mutations cause early onset pituitary ACTH deficiency. Genes Dev 2003;17:711-716.
14. Sanno N, Teramoto A, Osamura RY, Horvath E, Kovacs K, Lloyd RV, Scheithauer BW: Pathology of pituitary tumors. Neurosurg Clin N Am 2003;14:25-39.
15. Osamura RY, Watanabe K: Immunohistochemical studies of human FSH producing pituitary adenomas. Virchows Arch A Pathol Anat Histopathol 1988;413:61-68.
16. Tahara S, Kurotani R, Ishii Y, Sanno N, Teramoto A, Osamura RY: A case of Cushing's disease caused by pituitary adenoma producing adrenocorticotropic hormone and growth hormone concomitantly: Aberrant expression of transcription factors NeuroD1 and Pit-1 as a proposed mechanism. Mod Pathol 2002;15:1102-1105.
17. Kovacs K, Horvath E, Stefaneanu L, Bilbao J, Singer W, Muller PJ, Thapar K, Stone E: Pituitary adenoma producing growth hormone and adrenocorticotropin: A histological, immunocytochemical, electron microscopic, and in situ hybridization study. Case report. J Neurosurg 1998;88: 1111-1115.
18. Kurotani R, Yoshimura S, Iwasaki Y, Inoue K, Teramoto A, Osamura RY: Exogenous expression of Pit-1 in AtT-20 corticotropic cells induces endogenous growth hormone gene transcription. J Endocrinol 2002;172:477-487.
19. Osamura RY, Oda K, Utsunomiya H, Inada K, Umemura S, Shibuya M, Katakami H, Voss JW, Mayo KE, Rosenfeld MG: Immunohistochemical expression of PIT-1 protein in pituitary glands of human GRF transgenic mice: Its relationship with hormonal expressions. Endocr J 1993;40: 133-139.
20. Heaney AP, Melmed S: Pituitary tumour-transforming gene: A novel factor in pituitary tumour formation. Baillières Best Pract Res Clin Endocrinol Metab 1999;13:367-380.
21. Nakayama K, Ishida N, Shirane M, Inomata A, Inoue T, Shishido N, Horii I, Loh DY, Nakayama K: Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia and pituitary tumors. Cell 1996;85:707-720.
22. Hentges ST, Low MJ: Ovarian dependence for pituitary tumorigenesis in D2 dopamine receptordeficient mice. Endocrinology 2002;143:4536-4543.